Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Backers
1
Norrsken
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Ravel revolutionizes textile recycling through purification technology, effectively separating and repurposing blended materials. Join us…
Renasens11-50 employees
Waterless textile recycling that keeps fiber quality intact. Transform textile waste into clean, recycled fibers at scale with our…
CyclotheFounded 2023
We Are Redesigning Textile Waste Management. Cyclothe transforms how textile waste is collected and sorted—digitally, intelligently, and…
FairbricsVenture round $23.8M · 3 yr ago • Founded 2019 • 11-50 employees
Fairbrics develops a chemical process that turns captured carbon dioxide into polyester fibre for the textile industry. Its technology…
Sourgum8 roles
Sourgum unifies thousands of local haulers to deliver scalable, tech-powered waste and recycling solutions with transparency, reliability…
ECOMMITFounded 2020 • 1 role
ECOMMIT is a circular trading company committed to the earth. We connect all needs with all wants to realize a recycling-oriented society…

Overview

Syre is a textile impact company with a mission to decarbonize and dewaste the industry through textile-to-textile recycling at hyperscale.

News

News YahooFinance 28 days ago
Spyre (SYRE) Fell 13% on Its Weakest Program. Its Best One Just Worked
Spyre Therapeutics, Inc. (NASDAQ:SYRE) fell 13% to $94 on August 26, 2026, but the sell-off sharply overreacted to the underlying data. The company's SPY072 asset, tested in a rheumatoid arthritis sub-study of the Phase 2 SKYWAY trial reported August 25,
Read more
Report
News YahooFinance 5 months ago
Is Spyre Therapeutics (SYRE) One of the Small-Cap Stocks That Are On Fire Right Now?
Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the small-cap stocks that are on fire right now. On April 16, Spyre Therapeutics successfully closed an underwritten public offering, generating $463.5 million in gross proceeds. The final total reflects the
Read more
Report
News Nasdaq 2 years ago
Spyre Therapeutics is Now Oversold (SYRE)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength
Read more
Report